These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31868031)

  • 1. Safety of nalmefene for the treatment of alcohol use disorder: an update.
    López-Pelayo H; Zuluaga P; Caballeria E; Van den Brink W; Mann K; Gual A
    Expert Opin Drug Saf; 2020 Jan; 19(1):9-17. PubMed ID: 31868031
    [No Abstract]   [Full Text] [Related]  

  • 2. Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study.
    Di Nicola M; De Filippis S; Martinotti G; De Risio L; Pettorruso M; De Persis S; Maremmani AGI; Maremmani I; di Giannantonio M; Janiri L
    Adv Ther; 2017 Jul; 34(7):1636-1649. PubMed ID: 28540656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
    Mann K; Bladström A; Torup L; Gual A; van den Brink W
    Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
    van den Brink W; Strang J; Gual A; Sørensen P; Jensen TJ; Mann K
    Expert Opin Drug Saf; 2015 Apr; 14(4):495-504. PubMed ID: 25652768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ▼Nalmefene for alcohol dependence.
    Drug Ther Bull; 2014 May; 52(5):54-7. PubMed ID: 24809337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C; Laviolle B; Boussageon R; Reymann JM; Bellissant E; Naudet F
    PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of nalmefene in Japanese patients with alcohol dependence.
    Higuchi S; Takahashi M; Murai Y; Tsuneyoshi K; Nakamura I; Meulien D; Miyata H
    Psychiatry Clin Neurosci; 2020 Aug; 74(8):431-438. PubMed ID: 32359104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nalmefene for the treatment of alcohol dependence: a current update.
    Soyka M
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):675-84. PubMed ID: 24246244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
    Soyka M
    Expert Opin Pharmacother; 2016; 17(4):619-26. PubMed ID: 26810044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience about an unexpected adverse event during nalmefene treatment in two patients with alcohol use disorder.
    Milano G; Zavan V; Natta WM; Martelli A; Mattioli F
    J Clin Pharm Ther; 2016 Feb; 41(1):97-100. PubMed ID: 26714742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.
    Barrio P; Ortega L; Guardia J; Roncero C; Yuguero L; Gual A
    Clin Drug Investig; 2018 Feb; 38(2):147-155. PubMed ID: 29080208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
    Soyka M; Friede M; Schnitker J
    Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nalmefene: a novel pharmacotherapeutic option for alcoholism].
    Soyka M
    Nervenarzt; 2014 May; 85(5):578-82. PubMed ID: 24126432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study.
    van den Brink W; Sørensen P; Torup L; Mann K; Gual A;
    J Psychopharmacol; 2014 Aug; 28(8):733-44. PubMed ID: 24671340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benefits in reducing alcohol consumption: how nalmefene can help].
    Bendimerad P; Blecha L
    Encephale; 2014 Dec; 40(6):495-500. PubMed ID: 25454365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
    Gual A; He Y; Torup L; van den Brink W; Mann K;
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
    Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
    J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.